-
Fierce Biotech names Incyclix Bio a “Fierce 15” Biotech Company of 2025
22 Sep 2025 13:00 GMT
… most innovative and promising private biotechnology companies in the industry. … report has spotlighted the private biotechs pushing science into uncharted … About Fierce Biotech
Fierce Biotech covers the biopharma waterfront, from drug development through …
-
Development of HPLC-MS/MS Method for Simultaneous Detection of Esketamine and Norketamine: Application to Pharmacokinetics Drug Interactions Affected by Dexmedetomidine
22 Sep 2025 13:16 GMT
… polypharmacy may lead to unforeseen drug-drug interactions (DDIs), potentially compromising … were purchased from Hubei Yizhicheng Biotechnology Co., Ltd. The experiment … . In terms of pharmacodynamics, drugs used in combination with dexmedetomidine …
-
Pfizer boosts obesity drug prospects with $7.3 billion deal to buy Metsera
22 Sep 2025 13:11 GMT
… nearly 43% premium to the biotech company's Friday… develop its own lead obesity drug candidate, danuglipron, before deciding … also includes a monthly drug targeting a hormone called … said Metsera's experimental drugs "should accelerate" …
-
Pfizer to buy Metsera for $4.9 billion in obesity drug bet
22 Sep 2025 14:16 GMT
… handful of experimental weight-loss drugs, including a shot that could … often than the market-leading drugs from Eli Lilly & … gentler option to GLP-1 drugs like Wegovy and Zepbound, … to license another amylin drug from Danish biotech Zealand Pharma A…
-
Pfizer Nears $7.3 Billion Acquisition of Weight-Loss Biotech Metsera
22 Sep 2025 13:27 GMT
… fast-growing weight-loss drug market.
According to sources … its own experimental weight-loss drug, danuglipron, failed in clinical … billion purchase of cancer-focused biotech Seagen in 2023.
Metsera, … therapies, as well as drugs that harness the hormone amylin …
-
BIO on the American Road: Everything’s big in Texas, including biotech
22 Sep 2025 14:17 GMT
… adding that Food and Drug Administration (FDA) Commissioner Marty … “Enhancing U.S. Biotechnology Security within the Houston … can maintain its global biotech leadership. Topics ranged from … the national conversation on biotechnology security and growth.”
iC3 …
-
MapLight Keeps Biopharma’s IPO Flame Alight to Advance Alzheimer’s, Schizophrenia Drugs
22 Sep 2025 12:05 GMT
… year became the first novel drug for schizophrenia in more than … months-long IPO drought. The biotech initially aimed for a $263 …
-
MBX Biosciences Catapults 125%, Hitting A Nine-Month High, On Thyroid Drug Promise
22 Sep 2025 14:47 GMT
… experimental thyroid disease treatment.
The biotech company is testing a weekly … all patients knowingly receive the drug — 79% of patients were responders …
-
Biognosys to Launch Metabolomics/Lipidomics Services for Multiomics Drug Discovery and Clinical Research
22 Sep 2025 12:00 GMT
… Partnering with the most innovative biotech and pharmaceutical companies worldwide, Biognosys … next-generation proteomics to accelerate drug discovery and development, and … types into actionable biomarkers, accelerated drug development, and more precise …
-
Biotech specialist Argenx joins Euro Stoxx 50 index
22 Sep 2025 10:25 GMT
Belgian biotech company Argenx is joining the … spark new interest in the biotech sector, which has long been … rare conditions. Sales of the drug in the second quarter of …